Document is current
Any future updates will be listed below
-
Authors
Korda, Alexandra I. https://orcid.org/0000-0001-8843-4951
Andreou, Christina https://orcid.org/0000-0002-6656-9043
Ruef, Anne
Hahn, Lisa
Schmidt, André
Dannlowski, Udo
Kambeitz-Ilankovic, Lana
Dwyer, Dominic B.
Kambeitz, Joseph
Wenzel, Julian
Ruhrmann, Stephan https://orcid.org/0000-0002-6022-2364
Wood, Stephen J.
Salokangas, Raimo K. R.
Pantelis, Christos https://orcid.org/0000-0002-9565-0238
Schultze-Lutter, Frauke https://orcid.org/0000-0003-1956-9574
Meisenzahl, Eva
Brambilla, Paolo
Selvaggi, Pierluigi
Bertolino, Alessandro
Hietala, Jarmo
Upthegrove, Rachel https://orcid.org/0000-0001-8204-5103
Lalousis, Paris Alexandros
Riecher-Rössler, Anita
Davatzikos, Christos
Lencer, Rebekka
Koutsouleris, Nikolaos https://orcid.org/0000-0001-6825-6262
Borgwardt, Stefan https://orcid.org/0000-0002-5792-3987
,
- License Information
-
More Information
Article History
Received: 24 March 2023
Accepted: 17 October 2023
First Online: 2 January 2024
Competing interests
: N.K. received grants from the European Union (EU) during the conduct of the study and has a patent (US20160192889A1) issued. S.R. received grants from the European Commission during the conduct of the study. A.R.-R. received grants from the EU during the conduct of the study. C.A. received non-financial support from Sunovion Pharmaceuticals, Inc. and H. Lundbeck A/S outside the submitted work. A.R.-R. received grants from The Zurich Program for Sustainable Development of Mental Health Services (for Zurich Early Recognition Program (ZInEP)) and support from a private donation. C.P. received grants from Australian National Health and the Medical Research Council during the conduct of the study and personal fees from H. Lundbeck A/S and Australia Pty Ltd outside the submitted work. R.U. received personal fees from Sunovion Pharmaceuticals, Inc. outside the submitted work. E.M. has a patent (US20160192889A1) licensed. No other disclosures were reported.
